VITA RESOURCES LLC – Trademark Portfolio

Entity Type: 16

VITA RESOURCES LLC holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 3 trademarks are registered and 1 is pending. Notable registered marks include VITA GLOBE and VG VITA-GLOBE. The owner is based in BOHEMIA, NY.

60 ORVILLE DRIVE

BOHEMIA, NY 11716

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

VITA RESOURCES LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

35
Advertising & Business (3 filings)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does VITA RESOURCES LLC have?

VITA RESOURCES LLC has 6 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 pending, 2 cancelled.

What trademark classes does VITA RESOURCES LLC file in?

VITA RESOURCES LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are VITA RESOURCES LLC's most well-known trademarks?

VITA RESOURCES LLC's registered trademark portfolio includes well-known marks such as VITA GLOBE and VG VITA-GLOBE. These are among 3 currently registered trademarks in the portfolio.

What is VITA RESOURCES LLC's trademark registration success rate?

VITA RESOURCES LLC has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 1 application is pending review.